Description

Polymerase chain reaction (PCR) is a laboratory technique for rapidly producing (amplifying) millions to billions of copies of a specific segment of DNA, which can then be studied in greater detail. The global polymerase chain reaction (PCR) market is poised to grow by US$ 3.7 billion from 2022 to 2028, registering a CAGR of 5.5% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for polymerase chain reaction (PCR). The global polymerase chain reaction (PCR) market is segmented on the basis of product, technology, application, and region. By product, the global polymerase chain reaction (PCR) market has been segmented into instruments, reagents and consumables, services, software. The reagents and consumables segment was the largest contributor to the global polymerase chain reaction (PCR) market in 2021. Based upon technology, the global polymerase chain reaction (PCR) market is categorized into assembly and nested PCR, inverse PCR, multiplex PCR, real-time PCR, reverse transcriptase (RT) PCR, others. According to the research, the real-time PCR segment had the largest share in the global polymerase chain reaction (PCR) market. On the basis of application, the global polymerase chain reaction (PCR) market has been segmented into research, clinical, others. The research segment held the largest revenue share in 2021. In terms of geography, the global polymerase chain reaction (PCR) market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the polymerase chain reaction (PCR) market.

The global polymerase chain reaction (PCR) market is highly competitive. As of 2021, the major players in the global polymerase chain reaction (PCR) market were Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, BioFire Diagnostics LLC, Bio-Rad Laboratories Inc., Eppendorf AG, F. Hoffmann-LaRoche Ltd., GE Healthcare, Hologic Inc., Merck KGaA (Sigma-Aldrich), QIAGEN N.V., Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the polymerase chain reaction (PCR) market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: instruments, reagents and consumables, services, software
Technology: assembly and nested PCR, inverse PCR, multiplex PCR, real-time PCR, reverse transcriptase (RT) PCR, others
Application: research, clinical, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global polymerase chain reaction (PCR) market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Polymerase chain reaction (PCR) market overview
Part 3. Market breakdown by product
– Instruments
– Reagents and consumables
– Services
– Software
Part 4. Market breakdown by technology
– Assembly and nested PCR
– Inverse PCR
– Multiplex PCR
– Real-time PCR
– Reverse transcriptase (RT) PCR
– Others
Part 5. Market breakdown by application
– Research
– Clinical
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Abbott Laboratories
– Agilent Technologies Inc.
– Becton, Dickinson and Company
– BioFire Diagnostics LLC
– Bio-Rad Laboratories, Inc.
– Eppendorf AG
– F. Hoffmann-LaRoche Ltd.
– GE Healthcare
– Hologic Inc.
– Merck KGaA (Sigma-Aldrich)
– QIAGEN N.V.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer